AEM
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiedemann, I.
Right arrow Articles by Martínez, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiedemann, I.
Right arrow Articles by Martínez, B.
Agricola
Right arrow Articles by Wiedemann, I.
Right arrow Articles by Martínez, B.

 Previous Article  |  Next Article 

Applied and Environmental Microbiology, April 2006, p. 2809-2814, Vol. 72, No. 4
0099-2240/06/$08.00+0     doi:10.1128/AEM.72.4.2809-2814.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Lipid II-Based Antimicrobial Activity of the Lantibiotic Plantaricin C

Imke Wiedemann,1 Tim Böttiger,1 Raquel Regina Bonelli,1 Tanja Schneider,1 Hans-Georg Sahl,1 and Beatriz Martínez2*

Institut für Medizinische Mikrobiologie und Immunologie—Pharmazeutische Mikrobiologie, Universität Bonn, D-53115 Bonn, Germany,1 Instituto de Productos Lácteos de Asturias, IPLA-CSIC, 33300 Villaviciosa, Asturias, Spain2

Received 29 October 2005/ Accepted 20 January 2006

We analyzed the mode of action of the lantibiotic plantaricin C (PlnC), produced by Lactobacillus plantarum LL441. Compared to the well-characterized type A lantibiotic nisin and type B lantibiotic mersacidin, which are both able to interact with the cell wall precursor lipid II, PlnC displays structural features of both prototypes. In this regard, we found that lipid II plays a key role in the antimicrobial activity of PlnC besides that of pore formation. The pore forming activity of PlnC in whole cells was prevented by shielding lipid II on the cell surface. However, in contrast to nisin, PlnC was not able to permeabilize Lactococcus lactis cells or to form pores in 1,2-dioleoyl-sn-glycero-3-phosphocholine liposomes supplemented with 0.1 mol% purified lipid II. This emphasized the different requirements of these lantibiotics for pore formation. Using cell wall synthesis assays, we identified PlnC as a potent inhibitor of (i) lipid II synthesis and (ii) the FemX reaction, i.e., the addition of the first Gly to the pentapeptide side chain of lipid II. As revealed by thin-layer chromatography, both reactions were clearly blocked by the formation of a PlnC-lipid I and/or PlnC-lipid II complex. On the basis of the in vivo and in vitro activities of PlnC shown in this study and the structural lipid II binding motifs described for other lantibiotics, the specific interaction of PlnC with lipid II is discussed.

* Corresponding author. Mailing address: Instituto de Productos Lácteos de Asturias, IPLA-CSIC, Carretera de Infiesto s/n, Apdo. 85, 33300 Villaviciosa, Asturias, Spain. Phone: 34 985 89 33 59. Fax: 34 985 89 22 33. E-mail: bmf1{at}ipla.csic.es.

Applied and Environmental Microbiology, April 2006, p. 2809-2814, Vol. 72, No. 4
0099-2240/06/$08.00+0     doi:10.1128/AEM.72.4.2809-2814.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Microbiol. Mol. Biol. Rev. Eukaryot. Cell All ASM Journals

Copyright © 2006 by the American Society for Microbiology. All rights reserved.